[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].

Bing-Bing Zhao, Zheng Zhu, Pengpeng Xu, Junmin Li, Zhixiang Shen, Weili Zhao, Li WangPubMed 2013

Abstract

Elderly AML patients should be treated individually. The intermediate-dose cytarabine consolidation might not improve survival of elderly AML patients.
BibTeX
@inproceedings{zhao2013prognostic,
  author = {Bing-Bing Zhao and Zheng Zhu and Pengpeng Xu and Junmin Li and Zhixiang Shen and Weili Zhao and Li Wang},
  title = {{[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].}},
  booktitle = {PubMed},
  year = {2013},
}

Loading related content...

Figure